Zoledronic Acid 5mg/100ml Solution For Infusion
Out of date information, search anotherPACKAGE LEAFLET: INFORMATION FOR THE USER
Zoledronic Acid 5mg/100ml Solution for Infusion
(Referred to as Zoledronic Acid Infusion in the remainder of this leaflet)
T3
£
■p
E
no
JO
T3
£
€
'!3-
E
E
£
00
JO
Read all of this leaflet carefully
before you start taking this
medicine because it contains
important information for you.
- Keep this leaflet. You may need to read it again.
- If you have any further questions, ask your doctor, pharmacist or nurse.
- If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4.
What is in this leaflet:
1. What Zoledronic Acid Infusion is and what it is used for
2. What you need to know before you are given Zoledronic Acid Infusion
3. How Zoledronic Acid Infusion is given
4. Possible side effects
5. How to store Zoledronic Acid Infusion
6. Contents of the pack and other information
T3
£
€
'-O
1. WHAT ZOLEDRONIC ACID INFUSION IS AND WHAT IT IS USED FOR
T3
£
€
E
E
£
00
JO
T3
£
€ f ,
Zoledronic Acid Infusion contains the active substance zoledronic acid. It belongs to a group of medicines called bisphosphonates and is used to treat Paget's disease of the bone in adults.
Paget's disease of the bone
It is normal that old bone is removed and is replaced with new bone material. This process is called remodelling. In Paget's disease, bone remodelling is too rapid and new bone is formed in a disordered fashion, which makes it weaker than normal. If the disease is not treated, bones may become deformed and painful, and may break. Zoledronic Acid Infusion works by returning the bone remodelling process to normal, securing formation of normal bone, thus restoring strength to the bone.
18 years of age. The use of Zoledronic Acid Infusion in children and adolescents has not been studied.
Other medicines and Zoledronic Acid Infusion
Please tell your doctor, pharmacist or nurse if you are taking or have recently taken any other medicines, including medicines obtained without a prescription.
It is especially important for your doctor to know all the medicines you are taking, especially if you are taking any medicines known to be harmful to your kidneys (e.g. aminoglycosides) or diuretics ("water pills”) that may cause dehydration.
Pregnancy and breast-feeding
You must not be given Zoledronic Acid Infusion if you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby.
Ask your doctor, pharmacist or nurse for advice before taking this medicine.
Driving and using machines
Zoledronic Acid Infusion has no or negligible influence on the ability to drive and use machines. If you feel dizzy while taking Zoledronic Acid Infusion, do not drive or use machines until you feel better.
Important information about some of the ingredients of Zoledronic Acid Infusion
This medicinal product contains less than 1 mmol sodium (23mg) per dose, i.e. essentially 'sodium-free'.
3. HOW ZOLEDRONIC ACID INFUSION IS GIVEN
T3
£
-C
+w
00
£
£
CP
2. WHAT YOU NEED TO KNOW BEFORE YOU ARE GIVEN ZOLEDRONIC ACID INFUSION
T3
£
0\
£
£
rs
oq
CP.
5 £ £ s
co
O -
*— rrj
no -•
fY-l
5 £ *2 £ »c ^
CO
^ -
Follow all instructions given to you by your doctor, pharmacist or nurse carefully before you are given Zoledronic Acid Infusion.
You must not be given Zoledronic Acid Infusion
• if you are allergic to zoledronic acid, other bisphosphonates or any of the other ingredients of this medicine (listed in section 6).
- if you have hypocalcaemia (this means that the levels of calcium in your blood are too low).
- if you have severe kidney problems.
- if you are pregnant.
- if you are breast-feeding.
Warnings and precautions
Talk to your doctor before you are given Zoledronic Acid Infusion:
• if you are being treated with other medicines containing the active substance zoledronic acid.
- if you have a kidney problem, or used to have one.
- if you are unable to take daily calcium supplements.
- if you have had some or all of the parathyroid glands in your neck surgically removed.
- if you have had sections of your intestine removed.
Before you receive treatment with Zoledronic Acid Infusion, tell your doctor if you have (or have had) pain, swelling or numbness in your gums, jaw or both, if your jaw feels heavy, or if you have lost a tooth. Before you receive dental treatment or undergo dental surgery, tell your dentist you are receiving treatment with Zoledronic Acid Infusion.
Monitoring test
Your doctor should do a blood test to check your kidney function (levels of creatinine) before each dose of Zoledronic Acid Infusion. It is important for you to drink at least two glasses of fluid (such as water), within a few hours before receiving Zoledronic Acid Infusion, as directed by your healthcare provider.
Children and adolescents
Zoledronic Acid Infusion is not recommended for anyone under
Follow carefully all instructions given to you by your doctor or nurse. Check with your doctor or nurse if you are not sure.
Paget's disease
The usual dose is 5 mg, given to you as one initial infusion into a vein by your doctor or nurse. The infusion will take at least 15 minutes. Zoledronic Acid Infusion may work for longer than one year, and your doctor will let you know if you need to be treated again.
Your doctor may advise you to take calcium and vitamin D supplements (e.g. tablets) for at least the first ten days after being given Zoledronic Acid Infusion. It is important that you follow this advice carefully so that the level of calcium in your blood does not become too low in the period after the infusion. Your doctor will inform you regarding the symptoms associated with hypocalcaemia.
Zoledronic Acid Infusion with food and drink
Make sure you drink enough fluids (at least one or two glasses) before and after the treatment with Zoledronic Acid Infusion, as directed by your doctor. This will help to prevent dehydration. You may eat normally on the day you are treated with Zoledronic Acid Infusion. This is especially important in patients who take diuretics ("water pills”) and in elderly patients.
If you missed a dose of Zoledronic Acid Infusion
Contact your doctor or hospital as soon as possible to re-schedule your appointment.
Before stopping Zoledronic Acid Infusion therapy
If you are considering stopping Zoledronic Acid Infusion treatment, please go to your next appointment and discuss this with your doctor. Your doctor will advise you and decide how long you should be treated with Zoledronic Acid Infusion.
If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse.
4. POSSIBLE SIDE EFFECTS
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Side effects related to the first infusion are very common (occurring in more than 30% of patients) but are less common following subsequent infusions.
106071/2
INFORMATION FOR HEALTHCARE PROFESSIONALS
T3
2!
£
LO
£
£
rs
cq
CP.
5 £ 2
vo —
«■— rp
Zoledronic Acid 5mg/100ml Solution for Infusion (Referred to as Zoledronic Acid Infusion in the remainder of this section)
Please refer to the Summary of Product Characteristics (SmPC) for further details on this product.
How to prepare and administer Zoledronic Acid Infusion
- Zoledronic Acid 5mg/100ml Solution for Infusion is ready for use.
For single use only. Any unused solution should be discarded. Only clear solution free from particles and
discolouration should be used. Zoledronic Acid Infusion must not be mixed or given intravenously with any other medicinal product and must be given through a separate vented infusion line at a constant infusion rate. The infusion time must not be less than 15 minutes. Zoledronic Acid Infusion must not be allowed to come into contact with any calcium-containing solutions. The infusion must be conducted according to standard medical practice.
106071/2
The majority of the side effects, such as fever and chills, pain in the muscles or joints, and headache, occur within the first three days following the dose of Zoledronic Acid Infusion. The symptoms are usually mild to moderate and go away within three days. Your doctor can recommend a mild pain reliever such as ibuprofen or paracetamol to reduce these side effects. The chance of experiencing these side effects decreases with subsequent doses of Zoledronic Acid Infusion.
Some side effects could be serious
Common (may affect up to 1 in 10 people)
• Irregular heart rhythm (atrial fibrillation). It is currently unclear whether Zoledronic Acid Infusion causes this irregular heart rhythm but you should report it to your doctor if you experience such symptoms after you have received Zoledronic Acid Infusion.
• Swelling and/or pain at the infusion site may occur.
Uncommon (may affect up to 1 in 100 people)
• Skin reactions such as redness.
• Swelling, redness, pain and itching to the eyes or eye sensitivity to light.
Not known (frequency cannot be estimated from the available data)
• Pain in the mouth, teeth and jaw, swelling or sores inside the mouth, numbness or a feeling of heaviness in the jaw, or loosening of a tooth. These could be signs of bone damage in the jaw (osteonecrosis). Tell your dentist immediately if you experience such symptoms.
• Kidney disorders (e.g. decreased urine output) may occur. Your doctor should do a blood test to check your kidney function before each dose of Zoledronic Acid Infusion. It is important for you to drink at least 2 glasses of fluid (such as water), within a few hours before receiving Zoledronic Acid Infusion, as directed by your healthcare provider.
If you experience any of the above side effects, you should contact your doctor immediately.
Zoledronic Acid Infusion may also cause other side effects
Very common (may affect more than 1 in 10 people)
Fever
Common (may affect up to 1 in 10 people)
Headache, dizziness, sickness, vomiting, diarrhoea, pain in the muscles, pain in the bones and/or joints, pain in the back, arms or legs, flu-like symptoms (e.g. tiredness, chills, joint and muscle pain), chills, feeling of tiredness and lack of interest, weakness, pain, feeling unwell.
In patients with Paget's disease: symptoms due to low blood calcium, such as muscle spasms, or numbness, or a tingling sensation especially in the area around the mouth have been reported.
Uncommon (may affect up to 1 in 100 people)
Flu, upper respiratory tract infections, decreased red cell count, loss of appetite, sleeplessness, sleepiness which may include reduced alertness and awareness, tingling sensation or numbness, extreme tiredness, trembling, temporary loss of consciousness, eye infection or irritation or inflammation with pain and redness, spinning sensation, increased blood pressure, flushing, cough, shortness of breath, upset stomach, abdominal pain, constipation, dry mouth, heartburn, skin rash, excessive sweating, itching, skin reddening, neck pain, stiffness in muscles, bones and/or joints, joint swelling, muscle spasms, shoulder pain, pain in your chest muscles and rib cage, joint inflammation, muscular weakness, abnormal kidney test results, abnormal frequent urination, swelling of hands, ankles or feet, thirst, toothache, taste disturbances.
Rare (may affect up to 1 in 1,000 people)
Unusual fracture of the thigh bone may occur rarely. Contact your doctor if you experience pain, weakness or discomfort in your thigh, hip or groin as this may be an early indication of a possible fracture of the thigh bone.
Not known (frequency cannot be
estimated from the available data) Severe allergic reactions including dizziness and difficulty breathing, swelling mainly of the face and throat, decreased blood pressure, dehydration secondary to post-dose symptoms such as fever, vomiting and diarrhoea.
Reporting of side effects
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting systems listed below:
For patients in the UK, please report side-effects via the Yellow Card Scheme at:
For patients in Malta, please contact the Medicines Authority, details as follows:
ADR Reporting The Medicines Authority Post-Licensing Directorate 203 Level 3, Rue D'Argens GZR-1368 Gzira Website:
e-mail:
postlicensing.medidnesauthority@gov.mt
By reporting side effects you can help provide more information on the safety of this medicine.
5. HOW TO STORE ZOLEDRONIC ACID INFUSION
Your doctor, pharmacist or nurse knows how to store Zoledronic Acid Infusion properly.
• Keep this medicine out of the sight and reach of children.
• Do not use this medicine after the expiry date which is stated on the carton and bottle after EXP. The expiry date refers to the last day of that month.
• The unopened bottle does not require any special storage conditions.
6. CONTENTS OF THE PACK AND OTHER INFORMATION
What Zoledronic Acid Infusion contains
• The active substance is zoledronic acid. Each bottle with 100 ml of solution contains 5 mg zoledronic acid anhydrous (as monohydrate). One ml solution contains 0.05 mg zoledronic acid (as monohydrate).
• The other ingredients are mannitol (E421), sodium citrate and water for injections.
What Zoledronic Acid Infusion looks like and contents of the pack
Zoledronic Acid Infusion is a clear and colourless solution. It comes in 100 ml plastic bottles as a ready-to-use solution for infusion. It is supplied in packs containing one bottle.
Marketing Authorisation Holder
Wockhardt UK Ltd, Ash Road North, Wrexham, LL13 9UF, UK.
Manufacturer
CP Pharmaceuticals Ltd, Ash Road North, Wrexham, LL13 9UF, UK.
Other formats:
To listen to or request a copy of this leaflet in Braille, large print or audio please call, free of charge: 0800 198 5000 (UK Only). Please be ready to give the following information:
|
Product name |
UK Reference number |
|
Zoledronic Acid 5mg/100ml Solution for Infusion |
PL 29831/0480 |
This is a service provided by the Royal National Institute of Blind People.
This medicinal product is authorised in the Member States of the EEA under the following names:
UK: Zoledronic Acid 5mg/100ml Solution for Infusion Malta: Zoledronic Acid 5mg/100ml Solution for Infusion
This leaflet was last revised in: 11/2013.
219°™ fwOCKHARDT
T3 £ -C 00
CP
vO
T3 £ -C oo
T3 £ -C oo
0\
CP
5 £
^ ip
-C ^
oo
O -
5 £ £ £
-C ^
co
rsi ^
no —
CP.
5 £
^ ip -C ^
co
^ -
How to store Zoledronic Acid
Infusion
- Keep this medicine out of the sight and reach of children.
- Do not use this medicine after the expiry date which is stated on the carton and bottle after EXP. The expiry date refers to the last day of that month.
- The unopened bottle does not require any special storage conditions.
- After opening the bottle, the product should be used immediately in order to avoid microbial contamination.
Marketing Authorisation Holder
Wockhardt UK Ltd Ash Road North Wrexham LL13 9UF UK
Marketing Authorisation Number
PL 29831/0480 MA 154/08201
£
£
rs
co
CP.
vo —
CP
pg2/2